Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021Alize J Ferrari, Masayuki Teramoto, Robert Kaba Alhassan et al.|The Lancet|2024Cited by 4.4k
Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life Years for 29 Cancer Groups From 2010 to 2019Jonathan Kocarnik, Etsay Woldu Anbesu, Kelly Compton et al.|JAMA Oncology|2021Cited by 2k
Burden of disease scenarios for 204 countries and territories, 2022–2050: a forecasting analysis for the Global Burden of Disease Study 2021Masayuki Teramoto, Shahzaib Ahmad, Hazim Ababneh et al.|The Lancet|2024Cited by 931
The global, regional, and national burden of oesophageal cancer and its attributable risk factors in 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017Farin Kamangar, Pawan Faris, Félix Carvalho et al.|The Lancet. Gastroenterology & hepatology|2020Cited by 643
Global, regional, and national burden of rheumatoid arthritis, 1990–2020, and projections to 2050: a systematic analysis of the Global Burden of Disease Study 2021Rachel Black, Azadeh Bashiri, Marita Cross et al.|The Lancet Rheumatology|2023Cited by 584